A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis

NCT00800202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: carboplatin
DRUG: erlotinib [Tarceva]
DRUG: paclitaxel

Sponsor

Hoffmann-La Roche